GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Healthcare AI Acquisition Corp (NAS:HAIA) » Definitions » Cash Ratio

HAIA (Healthcare AI Acquisition) Cash Ratio : 0.00 (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Healthcare AI Acquisition Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Healthcare AI Acquisition's Cash Ratio for the quarter that ended in Sep. 2024 was 0.00.

Healthcare AI Acquisition has a Cash Ratio of 0.00. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for Healthcare AI Acquisition's Cash Ratio or its related term are showing as below:

During the past 3 years, Healthcare AI Acquisition's highest Cash Ratio was 5.22. The lowest was 0.73. And the median was 2.01.

HAIA's Cash Ratio is not ranked *
in the Diversified Financial Services industry.
Industry Median: 2.38
* Ranked among companies with meaningful Cash Ratio only.

Healthcare AI Acquisition Cash Ratio Historical Data

The historical data trend for Healthcare AI Acquisition's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healthcare AI Acquisition Cash Ratio Chart

Healthcare AI Acquisition Annual Data
Trend Dec21 Dec22 Dec23
Cash Ratio
1.40 2.57 -

Healthcare AI Acquisition Quarterly Data
Feb21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Healthcare AI Acquisition's Cash Ratio

For the Shell Companies subindustry, Healthcare AI Acquisition's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Healthcare AI Acquisition's Cash Ratio Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Healthcare AI Acquisition's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Healthcare AI Acquisition's Cash Ratio falls into.



Healthcare AI Acquisition Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Healthcare AI Acquisition's Cash Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Healthcare AI Acquisition's Cash Ratio for the quarter that ended in Sep. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Healthcare AI Acquisition  (NAS:HAIA) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Healthcare AI Acquisition Cash Ratio Related Terms

Thank you for viewing the detailed overview of Healthcare AI Acquisition's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Healthcare AI Acquisition Business Description

Traded in Other Exchanges
N/A
Address
8 The Green, Suite 15614, Dover, DE, USA, 19901
Website
Healthcare AI Acquisition Corp is a blank check company.
Executives
Polar Asset Management Partners Inc. 10 percent owner 16 YORK STREET SUITE 2900, TORONTO A6 M5J 0E6
Atticus Ale, Llc 10 percent owner 8 THE GREEN, SUITE 15614, DOVER DE 19901
Zikang Wu director, 10 percent owner, officer: Chief Executive Officer PO BOX 309, UGLAND HOUSE, GRAND CAYMAN E9 KY1-1104
Yuerong Tang director 8 THE GREEN, SUITE 15614, DOVER DE 19901
Hao Tian director 8 THE GREEN, SUITE 15614, DOVER DE 19901
Zixun Jin director 8 THE GREEN, SUITE 15614, DOVER DE 19901
Weiyi Zheng director 8 THE GREEN, SUITE 15614, DOVER DE 19901
Robert Piconi director C/O HEALTHCARE AI ACQUISITION, 7 STANLEY GARDENS, LONDON X0 W112ND
Elizabeth K Weymouth director 55 HUDSON YARDS, 44TH FLOOR, NEW YORK NY 10001
Xavier Flinois director
James William Brooks director 7 STANLEY GARDENS, LONDON X0 W112ND
Patrick Hargutt director, officer: Chief Financial Officer 7 STANLEY GARDENS, LONDON X0 W112ND
Simon Lyall-cottle director, officer: Chief Executive Officer 7 STANLEY GARDENS, LONDON X0 W112ND
Healthcare Ai Acquisition Llc 10 percent owner 7 STANLEY GARDENS, LONDON X0 W112ND
Greg Caswill director C/O HEALTHCARE AI ACQUISITION, 7 STANLEY GARDENS, LONDON X0 W112ND